Validation of cDNA Microarray Analysis to Distinguish Tumor Type Ex Vivo

R Randall, Mark Wade, Karen H. Albritton, Cheryl M. Coffin, David E. Joyner

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Tissue biopsy alone is diagnostic in less than 10% of cases of metastatic bone disease with an unknown primary tumor. Accordingly, to delineate the neoplastic process in cases of metastatic bone disease, where the primary tumor cannot be determined with conventional modalities, new tools are attractive. Complementary deoxyribonucleic acid microarrays may be such a tool. Verification and validation of this technology for analysis of specimens ex vivo is mandatory if it is to be used to analyze the complexity of heterogenous biologic tissues. To convey the issues involved in the clinical application of cDNA microarray analysis of tumor specimens ex vivo, a set of experiments analyzing surgically resected human specimens is presented. The specific aims of the analysis were to assess cDNA microarray reproducibility of serial tissue preparations of tumor samples and to confirm that heterogeneity within a given clinical tumor specimen does not preclude this technique as a tool to discern tumor types. Complementary deoxyribonucleic microarray analysis, as it applies to heterogeneous clinical tumor samples in limited numbers, based on preliminary data, seems to be an appropriate but still experimental method for distinguishing tumor types.

Original languageEnglish (US)
JournalClinical Orthopaedics and Related Research
Issue number415 SUPPL.
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Microarray Analysis
Oligonucleotide Array Sequence Analysis
Neoplasms
Bone Diseases
Unknown Primary Neoplasms
Neoplastic Processes
Systems Analysis
Technology
Biopsy
DNA

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Validation of cDNA Microarray Analysis to Distinguish Tumor Type Ex Vivo. / Randall, R; Wade, Mark; Albritton, Karen H.; Coffin, Cheryl M.; Joyner, David E.

In: Clinical Orthopaedics and Related Research, No. 415 SUPPL., 01.01.2003.

Research output: Contribution to journalArticle

Randall, R ; Wade, Mark ; Albritton, Karen H. ; Coffin, Cheryl M. ; Joyner, David E. / Validation of cDNA Microarray Analysis to Distinguish Tumor Type Ex Vivo. In: Clinical Orthopaedics and Related Research. 2003 ; No. 415 SUPPL.
@article{160d15a0b86448b3a31497a3584c4513,
title = "Validation of cDNA Microarray Analysis to Distinguish Tumor Type Ex Vivo",
abstract = "Tissue biopsy alone is diagnostic in less than 10{\%} of cases of metastatic bone disease with an unknown primary tumor. Accordingly, to delineate the neoplastic process in cases of metastatic bone disease, where the primary tumor cannot be determined with conventional modalities, new tools are attractive. Complementary deoxyribonucleic acid microarrays may be such a tool. Verification and validation of this technology for analysis of specimens ex vivo is mandatory if it is to be used to analyze the complexity of heterogenous biologic tissues. To convey the issues involved in the clinical application of cDNA microarray analysis of tumor specimens ex vivo, a set of experiments analyzing surgically resected human specimens is presented. The specific aims of the analysis were to assess cDNA microarray reproducibility of serial tissue preparations of tumor samples and to confirm that heterogeneity within a given clinical tumor specimen does not preclude this technique as a tool to discern tumor types. Complementary deoxyribonucleic microarray analysis, as it applies to heterogeneous clinical tumor samples in limited numbers, based on preliminary data, seems to be an appropriate but still experimental method for distinguishing tumor types.",
author = "R Randall and Mark Wade and Albritton, {Karen H.} and Coffin, {Cheryl M.} and Joyner, {David E.}",
year = "2003",
month = "1",
day = "1",
doi = "10.1097/01.blo0000093060.96273.db",
language = "English (US)",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "415 SUPPL.",

}

TY - JOUR

T1 - Validation of cDNA Microarray Analysis to Distinguish Tumor Type Ex Vivo

AU - Randall, R

AU - Wade, Mark

AU - Albritton, Karen H.

AU - Coffin, Cheryl M.

AU - Joyner, David E.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Tissue biopsy alone is diagnostic in less than 10% of cases of metastatic bone disease with an unknown primary tumor. Accordingly, to delineate the neoplastic process in cases of metastatic bone disease, where the primary tumor cannot be determined with conventional modalities, new tools are attractive. Complementary deoxyribonucleic acid microarrays may be such a tool. Verification and validation of this technology for analysis of specimens ex vivo is mandatory if it is to be used to analyze the complexity of heterogenous biologic tissues. To convey the issues involved in the clinical application of cDNA microarray analysis of tumor specimens ex vivo, a set of experiments analyzing surgically resected human specimens is presented. The specific aims of the analysis were to assess cDNA microarray reproducibility of serial tissue preparations of tumor samples and to confirm that heterogeneity within a given clinical tumor specimen does not preclude this technique as a tool to discern tumor types. Complementary deoxyribonucleic microarray analysis, as it applies to heterogeneous clinical tumor samples in limited numbers, based on preliminary data, seems to be an appropriate but still experimental method for distinguishing tumor types.

AB - Tissue biopsy alone is diagnostic in less than 10% of cases of metastatic bone disease with an unknown primary tumor. Accordingly, to delineate the neoplastic process in cases of metastatic bone disease, where the primary tumor cannot be determined with conventional modalities, new tools are attractive. Complementary deoxyribonucleic acid microarrays may be such a tool. Verification and validation of this technology for analysis of specimens ex vivo is mandatory if it is to be used to analyze the complexity of heterogenous biologic tissues. To convey the issues involved in the clinical application of cDNA microarray analysis of tumor specimens ex vivo, a set of experiments analyzing surgically resected human specimens is presented. The specific aims of the analysis were to assess cDNA microarray reproducibility of serial tissue preparations of tumor samples and to confirm that heterogeneity within a given clinical tumor specimen does not preclude this technique as a tool to discern tumor types. Complementary deoxyribonucleic microarray analysis, as it applies to heterogeneous clinical tumor samples in limited numbers, based on preliminary data, seems to be an appropriate but still experimental method for distinguishing tumor types.

UR - http://www.scopus.com/inward/record.url?scp=0142157079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142157079&partnerID=8YFLogxK

U2 - 10.1097/01.blo0000093060.96273.db

DO - 10.1097/01.blo0000093060.96273.db

M3 - Article

C2 - 14600600

AN - SCOPUS:0142157079

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 415 SUPPL.

ER -